7 Recruiting Advanced Solid Tumor Clinical Trials in Massachusetts
Explore active advanced solid tumor research studies enrolling across Massachusetts. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Advanced Solid Tumor Studies in Massachusetts
🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Study in Advanced Solid Tumor Patients
📍 DFCI — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Anti-GD2 ADC M3554 in Advanced Solid Tumors
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
ARC101 in Advanced Solid Tumors
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔